MORGAN STANLEY (MS) Fundamental Analysis & Valuation

NYSE:MS • US6174464486

158.895 USD
-1.85 (-1.15%)
Last: Mar 11, 2026, 11:36 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This MS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

MS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 242 industry peers in the Capital Markets industry. MS may be in some trouble as it scores bad on both profitability and health. MS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. MS Profitability Analysis

1.1 Basic Checks

  • In the past year MS was profitable.
  • In the past year MS has reported a negative cash flow from operations.
  • Each year in the past 5 years MS has been profitable.
  • In multiple years MS reported negative operating cash flow during the last 5 years.
MS Yearly Net Income VS EBIT VS OCF VS FCFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B 40B

1.2 Ratios

  • MS has a worse Return On Assets (1.14%) than 63.22% of its industry peers.
  • MS's Return On Equity of 14.15% is fine compared to the rest of the industry. MS outperforms 73.55% of its industry peers.
  • MS's Return On Invested Capital of 1.46% is on the low side compared to the rest of the industry. MS is outperformed by 64.46% of its industry peers.
Industry RankSector Rank
ROA 1.14%
ROE 14.15%
ROIC 1.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MS Yearly ROA, ROE, ROICMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • MS has a Profit Margin (13.32%) which is in line with its industry peers.
  • In the last couple of years the Profit Margin of MS has declined.
  • MS's Operating Margin of 18.06% is in line compared to the rest of the industry. MS outperforms 41.74% of its industry peers.
  • MS's Operating Margin has declined in the last couple of years.
  • With a decent Gross Margin value of 54.99%, MS is doing good in the industry, outperforming 63.64% of the companies in the same industry.
  • In the last couple of years the Gross Margin of MS has declined.
Industry RankSector Rank
OM 18.06%
PM (TTM) 13.32%
GM 54.99%
OM growth 3Y-4.95%
OM growth 5Y-7.71%
PM growth 3Y-5.29%
PM growth 5Y-7.41%
GM growth 3Y-10.21%
GM growth 5Y-8.75%
MS Yearly Profit, Operating, Gross MarginsMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. MS Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for MS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MS Yearly Shares OutstandingMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
MS Yearly Total Debt VS Total AssetsMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B 800B 1T

2.2 Solvency

  • MS has an Altman-Z score of -0.08. This is a bad value and indicates that MS is not financially healthy and even has some risk of bankruptcy.
  • MS's Altman-Z score of -0.08 is on the low side compared to the rest of the industry. MS is outperformed by 77.27% of its industry peers.
  • MS has a Debt/Equity ratio of 7.41. This is a high value indicating a heavy dependency on external financing.
  • MS's Debt to Equity ratio of 7.41 is on the low side compared to the rest of the industry. MS is outperformed by 87.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.41
Debt/FCF N/A
Altman-Z -0.08
ROIC/WACCN/A
WACCN/A
MS Yearly LT Debt VS Equity VS FCFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

  • A Current Ratio of 0.30 indicates that MS may have some problems paying its short term obligations.
  • MS has a worse Current ratio (0.30) than 81.41% of its industry peers.
  • A Quick Ratio of 0.30 indicates that MS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.30, MS is doing worse than 81.41% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.3
Quick Ratio 0.3
MS Yearly Current Assets VS Current LiabilitesMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200B 400B 600B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. MS Growth Analysis

3.1 Past

  • MS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.59%, which is quite impressive.
  • Measured over the past years, MS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 9.28% on average per year.
  • Looking at the last year, MS shows a quite strong growth in Revenue. The Revenue has grown by 11.54% in the last year.
  • MS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.86% yearly.
EPS 1Y (TTM)28.59%
EPS 3Y18.47%
EPS 5Y9.28%
EPS Q2Q%20.72%
Revenue 1Y (TTM)11.54%
Revenue growth 3Y21.98%
Revenue growth 5Y17.86%
Sales Q2Q%10.28%

3.2 Future

  • MS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.40% yearly.
  • MS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.42% yearly.
EPS Next Y14.24%
EPS Next 2Y11.25%
EPS Next 3Y9.4%
EPS Next 5Y8.4%
Revenue Next Year8.79%
Revenue Next 2Y7.07%
Revenue Next 3Y6.18%
Revenue Next 5Y5.42%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MS Yearly Revenue VS EstimatesMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
MS Yearly EPS VS EstimatesMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

3

4. MS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 15.56, which indicates a correct valuation of MS.
  • Compared to the rest of the industry, the Price/Earnings ratio of MS is on the same level as its industry peers.
  • MS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.25, which is the current average of the S&P500 Index.
  • Based on the Price/Forward Earnings ratio of 13.62, the valuation of MS can be described as correct.
  • MS's Price/Forward Earnings ratio is in line with the industry average.
  • MS is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.39, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.56
Fwd PE 13.62
MS Price Earnings VS Forward Price EarningsMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • MS's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MS is cheaper than 71.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.18
MS Per share dataMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.09
PEG (5Y)1.68
EPS Next 2Y11.25%
EPS Next 3Y9.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. MS Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.25%, MS has a reasonable but not impressive dividend return.
  • MS's Dividend Yield is comparable with the industry average which is at 6.64.
  • MS's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.25%

5.2 History

  • The dividend of MS is nicely growing with an annual growth rate of 18.94%!
  • MS has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)18.94%
Div Incr Years0
Div Non Decr Years0
MS Yearly Dividends per shareMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 41.70% of the earnings are spent on dividend by MS. This is a bit on the high side, but may be sustainable.
  • MS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP41.7%
EPS Next 2Y11.25%
EPS Next 3Y9.4%
MS Yearly Income VS Free CF VS DividendMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B -20B
MS Dividend Payout.MS Dividend Payout, showing the Payout Ratio.MS Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

MS Fundamentals: All Metrics, Ratios and Statistics

MORGAN STANLEY

NYSE:MS (3/11/2026, 11:36:03 AM)

158.895

-1.85 (-1.15%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)01-15
Earnings (Next)04-15
Inst Owners62.56%
Inst Owner Change-0.1%
Ins Owners0.19%
Ins Owner Change-0.01%
Market Cap251.53B
Revenue(TTM)119.66B
Net Income(TTM)15.56B
Analysts74.55
Price Target200.51 (26.19%)
Short Float %1.37%
Short Ratio2.33
Dividend
Industry RankSector Rank
Dividend Yield 2.25%
Yearly Dividend3.8
Dividend Growth(5Y)18.94%
DP41.7%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-30
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.52%
Min EPS beat(2)5.77%
Max EPS beat(2)29.27%
EPS beat(4)4
Avg EPS beat(4)19.15%
Min EPS beat(4)5.77%
Max EPS beat(4)29.27%
EPS beat(8)7
Avg EPS beat(8)14.05%
EPS beat(12)11
Avg EPS beat(12)10.53%
EPS beat(16)13
Avg EPS beat(16)8.07%
Revenue beat(2)2
Avg Revenue beat(2)3.7%
Min Revenue beat(2)1.43%
Max Revenue beat(2)5.96%
Revenue beat(4)4
Avg Revenue beat(4)4.02%
Min Revenue beat(4)1.43%
Max Revenue beat(4)5.96%
Revenue beat(8)7
Avg Revenue beat(8)2.74%
Revenue beat(12)9
Avg Revenue beat(12)10.9%
Revenue beat(16)12
Avg Revenue beat(16)9.91%
PT rev (1m)0.08%
PT rev (3m)15.8%
EPS NQ rev (1m)1.23%
EPS NQ rev (3m)1.08%
EPS NY rev (1m)0%
EPS NY rev (3m)7.51%
Revenue NQ rev (1m)2.17%
Revenue NQ rev (3m)2.2%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)3.09%
Valuation
Industry RankSector Rank
PE 15.56
Fwd PE 13.62
P/S 2.15
P/FCF N/A
P/OCF N/A
P/B 2.29
P/tB 2.89
EV/EBITDA 19.18
EPS(TTM)10.21
EY6.43%
EPS(NY)11.66
Fwd EY7.34%
FCF(TTM)-4.26
FCFYN/A
OCF(TTM)-2.32
OCFYN/A
SpS73.81
BVpS69.46
TBVpS55.05
PEG (NY)1.09
PEG (5Y)1.68
Graham Number126.32
Profitability
Industry RankSector Rank
ROA 1.14%
ROE 14.15%
ROCE 3.33%
ROIC 1.46%
ROICexc 1.61%
ROICexgc 1.69%
OM 18.06%
PM (TTM) 13.32%
GM 54.99%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.95%
OM growth 5Y-7.71%
PM growth 3Y-5.29%
PM growth 5Y-7.41%
GM growth 3Y-10.21%
GM growth 5Y-8.75%
F-Score4
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 7.41
Debt/FCF N/A
Debt/EBITDA 31.03
Cap/Depr 59.4%
Cap/Sales 2.63%
Interest Coverage 0.45
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.3
Quick Ratio 0.3
Altman-Z -0.08
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.59%
EPS 3Y18.47%
EPS 5Y9.28%
EPS Q2Q%20.72%
EPS Next Y14.24%
EPS Next 2Y11.25%
EPS Next 3Y9.4%
EPS Next 5Y8.4%
Revenue 1Y (TTM)11.54%
Revenue growth 3Y21.98%
Revenue growth 5Y17.86%
Sales Q2Q%10.28%
Revenue Next Year8.79%
Revenue Next 2Y7.07%
Revenue Next 3Y6.18%
Revenue Next 5Y5.42%
EBIT growth 1Y37.32%
EBIT growth 3Y15.93%
EBIT growth 5Y8.77%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y78.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y86.95%
OCF growth 3YN/A
OCF growth 5YN/A

MORGAN STANLEY / MS FAQ

Can you provide the ChartMill fundamental rating for MORGAN STANLEY?

ChartMill assigns a fundamental rating of 3 / 10 to MS.


What is the valuation status of MORGAN STANLEY (MS) stock?

ChartMill assigns a valuation rating of 3 / 10 to MORGAN STANLEY (MS). This can be considered as Overvalued.


What is the profitability of MS stock?

MORGAN STANLEY (MS) has a profitability rating of 3 / 10.


What is the valuation of MORGAN STANLEY based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MORGAN STANLEY (MS) is 15.56 and the Price/Book (PB) ratio is 2.29.


What is the expected EPS growth for MORGAN STANLEY (MS) stock?

The Earnings per Share (EPS) of MORGAN STANLEY (MS) is expected to grow by 14.24% in the next year.